Abstract:Pathological variants in SGMS2, encoding sphingomyelin synthase 2 (SMS2), result in a rare autosomal dominant skeletal disorder with cranial doughnut lesions. The disease manifests as early-onset osteoporosis or a more severe skeletal dysplasia with low bone mineral density, frequent fractures, long-bone deformities, and multiple sclerotic cranial lesions. The exact underlying molecular features and skeletal consequences, however, remain elusive. This study investigated bone tissue characteristics in two adult males with a heterozygous SGMS2 mutation p.Arg50* and significant bone fragility. Transiliac bone biopsy samples from both (patient 1: 61 years; patient 2: 29 years) were analyzed by bone histomorphometry, confocal laser scanning microscopy, and quantitative backscattered electron imaging (qBEI). Bone histomorphometry portrayed largely normal values for structural and turnover parameters, but in both patient 1 and patient 2, respectively, osteoid thickness (-1.80 SD, -1.37 SD) and mineralizing surface (-1.03 SD, -2.73 SD) were reduced and osteoid surface increased (+9.03 SD, +0.98 SD), leading to elevated mineralization lag time (+8.16 SD, +4.10 SD). qBEI showed low and heterogeneous matrix mineralization (CaPeak -2.41 SD, -3.72 SD; CaWidth +7.47 SD, +4.41 SD) with a chaotic arrangement of collagenous fibrils under polarized light. Last, osteocyte lacunae appeared abnormally large and round in shape and the canalicular network severely disturbed with short-spanned canaliculi lacking any orderliness or continuity. Taken together, these data underline a central role for functional SMS2 in bone matrix organization and mineralization, lacunocanalicular network, and in maintaining skeletal strength and integrity. These data bring new knowledge on changes in bone histology resulting from abnormal sphingomyelin metabolism and aid en route to better understanding of sphingolipid-related skeletal disorders. © 2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.

Deficiency of sphingomyelin synthase 1 but not sphingomyelin synthase 2 reduces bone formation due to impaired osteoblast differentiation

Inactivation of spermine synthase in mice causes osteopenia due to reduced osteoblast activity

Impact of Sphingomyelin Synthase 1 Deficiency on Sphingolipid Metabolism and Atherosclerosis in Mice

Abnormal Bone Tissue Organization and Osteocyte Lacunocanalicular Network in Early‐Onset Osteoporosis Due to SGMS2 Mutations

Sphingomyelin Synthase 2 is One of the Determinants for Plasma and Liver Sphingomyelin Levels in Mice

Targeting Sulfation-Dependent Mechanoreciprocity Between Matrix and Osteoblasts to Mitigate Bone Loss.

Deubiquitinase MYSM1 is Essential for Normal Bone Formation and Mesenchymal Stem Cell Differentiation

Effect of Liver Total Sphingomyelin Synthase Deficiency on Plasma Lipid Metabolism.

Deficiency of Macf1 in Osterix Expressing Cells Decreases Bone Formation by Bmp2/Smad/Runx2 Pathway

Macrophage Sphingomyelin Synthase 2 Deficiency Decreases Atherosclerosis in Mice

Embryonic ablation of osteoblast Smad4 interrupts matrix synthesis in response to canonical Wnt signaling and causes an osteogenesis-imperfecta-like phenotype

Serum Response Factor Regulates Bone Formation Via Igf-1 and Runx2 Signals

Ablation of Gsα Signaling in Osteoclast Progenitor Cells Adversely Affects Skeletal Bone Maintenance.

Role of collagen degradation pathway in sphingomyelin synthase 2-deficient mouse skin

Effect of Total SMS Activity on LDL Catabolism in Mice.

Abstract 410: Effect of Total Sphingomyelin Synthase Activity on Low Density Lipoprotein Catabolism

Membrane-type 1 Matrix Metalloproteinase Modulates Tissue Homeostasis by a Non-proteolytic Mechanism

The domain responsible for sphingomyelin synthase (SMS) activity.

Loss of BMP signaling mediated by BMPR1A in osteoblasts leads to differential bone phenotypes in mice depending on anatomical location of the bones.

Bmp2 in osteoblasts of periosteum and trabecular bone links bone formation to vascularization and mesenchymal stem cells

Shp2 Regulates Intramembranous Ossification By Modifying The Tgf Beta And Bmp2 Signaling Pathway